ReviewTranslational andrology and urology2018
Urethral diverticulum carcinoma in females-a case series and review of the English and Japanese literature.
Review in Translational andrology and urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 28 citations in OpenAlex.
- Urethral diverticulum carcinoma management: a case report and review of the literature.Journal of medical case reports · 2026Review
- Cystic genitourinary lesions in the pelvis: pearls and pitfalls.Abdominal radiology (New York) · 2025Review
- Rethinking Urethral Diverticulum: A Narrative Review of Clinical Outcomes and Cancer Associations.International urogynecology journal · 2025Review
- Magnetic resonance imaging of paraurethral and paravaginal lesion: relevant diagnoses, key findings and surgical correlation.Translational andrology and urology · 2025Review
- A diagnostic approach of various urethral diseases using multimodal imaging findings: comprehensive overview.Abdominal radiology (New York) · 2024Review
- Adenocarcinoma in a Female Urethral Diverticulum With Gastric Differentiation: A Case Report.Cureus · 2024Article
- Female urethral diverticular carcinoma: a case report and review of the literature.Frontiers in oncology · 2024Article
- CDX2- and PAX8-Expressing Subtypes in Female Urethral Adenocarcinoma: Pathogenesis Insights through Immunohistochemical and Morphological Analyses.Diagnostics (Basel, Switzerland) · 2023Article
- Management of Primary Female Urethral Adenocarcinoma: Two Rare Case Reports and Literature Review.Medicina (Kaunas, Lithuania) · 2023Review
- A rare case of a clear cell carcinoma in a female urethral diverticulum.IJU case reports · 2023Article
- Sarcomatoid urothelial carcinoma arising in the female urethral diverticulum.Journal of pathology and translational medicine · 2021Article
- Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas.The American journal of surgical pathology · 2020Article
- Clear cell carcinoma in a urethral diverticulum.Urology case reports · 2020Article
- Giant anterior urethra stones combined with a diverticulum: a case report.Annals of the Royal College of Surgeons of England · 2019Article
- Urinary incontinence secondary to a suspected congenital urethral deformity in a kitten.JFMS open reportsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aims of our study were to describe our case series of three urethral diverticulum carcinomas (UDC) in women and to review the literature on UDC in females to determine patient characteristics, presenting symptoms and outcomes along with optimal investigations and treatment modalities. A literature search was performed utilizing Medline, EMBASE and the Cochrane library for all papers including case reports on UDC in women published to date. The results along with those of our three cases are detailed. A total of 126 cases of UDC in women have been reported; 75% adenocarcinoma (Adenoca), 15% transitional cell carcinoma (TCC) and 10% squamous cell carcinoma (SCC). Median age at presentation was 53 years (range, 14-81 years). The commonest presenting symptoms were bleeding and retention. Cystoscopy, MRI and trans-urethral biopsy were the commonest methods of diagnosis. Treatment was radiotherapy +/- chemotherapy alone in 21%, local excision +/- radiotherapy in 44%, urethrectomy in 3% and anterior exenteration +/- radiotherapy in 32%. At last follow-up 63% were alive and well, 10% were alive with recurrent cancer and 25% had died from their disease. UDC is rare in women. It is predominantly adenocarcinoma. There is no established treatment and survival is at best moderate. An international registry and consensus on management is needed if this is to be improved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.